» Articles » PMID: 15343056

Drug-induced Neurobehavioral Plasticity: the Role of Environmental Context

Overview
Journal Behav Pharmacol
Date 2004 Sep 3
PMID 15343056
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Repeated administrations of addictive drugs produce long-lasting changes in brain and behavior. However, drug-induced neurobehavioral plasticity is not a mere function of the neuropharmacological actions of drugs, but the result of complex drug-environment interactions. In the present review we summarize results obtained in a series of studies using an animal model of drug-environment interaction, showing that environmental context and past drug history interact to modulate the effects of amphetamine, cocaine and morphine on behavior, gene expression and structural plasticity. These findings may help shed some light on the conditions necessary for addictive drugs to enduringly alter brain and behavior.

Citing Articles

Endogenous Regulator of G protein Signaling 14 (RGS14) suppresses cocaine-induced emotionally motivated behaviors in female mice.

Bramlett S, Foster S, Weinshenker D, Hepler J bioRxiv. 2024; .

PMID: 39314405 PMC: 11419016. DOI: 10.1101/2024.09.12.612719.


Heterogeneity in choice models of addiction: the role of context.

Acuff S, Strickland J, Smith K, Field M Psychopharmacology (Berl). 2024; 241(9):1757-1769.

PMID: 38990313 DOI: 10.1007/s00213-024-06646-1.


Is a Regulator of Cocaine Responses through Control of Striatal and Cortical Excitability and Drug-Induced Plasticity.

Mitra A, Deats S, Dickson P, Zhu J, Gardin J, Nieman B J Neurosci. 2024; 44(18).

PMID: 38508714 PMC: 11063827. DOI: 10.1523/JNEUROSCI.1389-23.2024.


Context-dependent effects of the CB1 receptor antagonist rimonabant on morphine-induced behavioral sensitization in female mice.

Marinho E, Oliveira-Lima A, Reis H, Santos-Baldaia R, Wuo-Silva R, Hollais A Front Pharmacol. 2023; 14:1100527.

PMID: 36814501 PMC: 9939462. DOI: 10.3389/fphar.2023.1100527.


Novel digital approaches to the assessment of problematic opioid use.

Freda Jr P, Kranzler H, Moore J BioData Min. 2022; 15(1):14.

PMID: 35840990 PMC: 9284824. DOI: 10.1186/s13040-022-00301-1.